Allergan (AGN) Tops Q4 EPS by 65c

Allergan (NYSE: AGN) reported Q4 EPS of $5.22, $0.65 better than the analyst estimate of $4.57. Revenue for the quarter came in at $4.35 billion versus the consensus estimate of $4.09 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c